Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | NCOA2 | Q15596 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5889177 | 1.00 | SNCA (0.48) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL5889194 | 1.00 | SNCA (0.48) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL5453288 | 1.00 | SNCA (0.48) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL197157 | 0.97 | SNCA (0.50) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL16140274 | 0.91 | SNCA (0.43) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL12964479 | 0.84 | SNCA (0.39) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL8508163 | 0.84 | MAPT (0.42) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL12964481 | 0.83 | SNCA (0.38) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL2778388 | 0.81 | SNCA (0.61) | SNCAMAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL4090912 | 0.81 | MAPT (0.44) | SNCAMAPTMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035592-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT | TOKUYAMA DENTAL CORPORATION (JP) | 2026-02-05 | — | — | US | disclosed |
| US-12202954-B2 | Rubber composition and crosslinked rubber molded product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-01-21 | — | — | US | disclosed |
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| WO-2024038705-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR 3D STEREOLITHOGRAPHY AND METHOD FOR PRODUCING 3D STEREOLITHOGRAPHY PRODUCT | 株式会社トクヤマデンタル | 2024-02-22 | — | — | WO | disclosed |
| EP-4310128-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | Tokuyama Dental Corporation (JP) | 2024-01-24 | — | — | EP | disclosed |
| EP-4310128-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | Tokuyama Dental Corporation (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20230114853-A1 | RUBBER COMPOSITION AND CROSSLINKED RUBBER MOLDED PRODUCT | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11312820-B2 | Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-04-26 | — | — | US | disclosed |
| US-20220081305-A1 | CRYSTAL, METHOD OF PRODUCING CRYSTAL, AND METHOD OF SELF-ORGANIZING SILANOL COMPOUND | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2022-03-17 | — | — | US | disclosed |
| US-20210115187-A1 | SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2021-04-22 | — | — | US | disclosed |
| US-20020061330-A1 | Supports for photosensitizer formulations | BRITISH COLUMBIA, THE UNIVERSITY OF (CA) | 2002-05-23 | — | — | US | disclosed |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | QLT INC. (CA) | 2002-02-21 | — | — | US | disclosed |
| WO-2001085212-A2 | DRUG DELIVERY SYSTEMS FOR PHOTODYNAMIC THERAPY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| EP-0668277-B1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN (FI) | 1998-11-04 | — | — | EP | disclosed |
| US-5556524-A | DIAGNOSTICS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1996-09-17 | — | — | US | disclosed |
| EP-0668277-A1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1995-08-23 | — | — | EP | disclosed |
| US-5180838-A | Terthienyl compounds as insecticides | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1993-01-19 | — | — | US | disclosed |
| US-5045563-A | Terthienyl Compound | HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 1991-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180788-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION | CRY1, CRY2, TYR | SNCA 1582/4885MAPT 162/4885MEN1 1163/4885 |
| US-11312820-B2 | Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes | INF2, ABL1, ICMT | SNCA 1576/4885MAPT 3729/4885MEN1 3665/4885 |
| US-20020061330-A1 | Supports for photosensitizer formulations | PPOX, PPIF, SDHA | SNCA 2565/4885MAPT 1710/4885MEN1 2343/4885 |
| US-20210115187-A1 | SOLUTION-PROCESSABLE INDENOFLUORENES AND METHODS TO GENERATE SOLUTION-PROCESSABLE INDENOFLUORENES | INF2, ABL1, ICMT | SNCA 1576/4885MAPT 3729/4885MEN1 3665/4885 |
| US-20260035592-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT | TERB1, CAD, C9 | SNCA 4501/4885MAPT 510/4885MEN1 2791/4885 |
| US-20020022032-A1 | Immuno-adjuvant PDT treatment of metastatic tumors | CD74, ANXA11, ANXA1 | SNCA 4090/4885MAPT 1243/4885MEN1 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.